Molndal, Sweden

Robert Andrew Judkins

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Molndal, SE (2012)
  • Mölndal, SE (2009 - 2022)

Company Filing History:


Years Active: 2009-2022

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Mind of Robert Andrew Judkins

Introduction

Robert Andrew Judkins, an accomplished inventor based in Molndal, Sweden, has made significant contributions to the field of pharmaceutical sciences. With a total of six patents to his name, Judkins focuses on developing compounds that modulate the farnesoid X receptor, aiming to tackle various health issues ranging from metabolic disorders to cancers.

Latest Patents

One of Judkins' most notable patents includes compounds that act as modulators of the farnesoid X receptor (FXR). These compounds are instrumental in addressing diseases such as bile acid-related disorders, metabolic syndrome, type-2 diabetes, and more. Specifically, the patent describes compounds classified as sulfinic acid compounds, which may exist as enantiomers, stereoisomers, tautomers, and other pharmacologically acceptable forms.

Another significant patent highlights azetidinyl compounds aimed at treating melanin-concentrating hormone-related diseases. The pharmaceutical compositions derived from these compounds demonstrate promising applications in both treatment and prophylactic measures.

Career Highlights

Judkins has collaborated with leading pharmaceutical companies, including AstraZeneca AB and Inorbit Therapeutics AB. His work involves extensive research and development in drug discovery and formulation, focusing on innovative therapeutic solutions that enhance patient care.

Collaborations

Throughout his career, Robert Andrew Judkins has partnered with notable colleagues such as Lanna Li and Anders Broo. These collaborations have allowed for shared expertise and resources, further driving the progress of his research and the impact of his inventions in the pharmaceutical field.

Conclusion

Robert Andrew Judkins exemplifies innovation through his research and patents related to the farnesoid X receptor and azetidinyl compounds. His contributions continue to pave the way for advancements in medical treatments, showcasing his dedication to improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…